Psych Congress 2023 Poster: EMPOWERing the Next Generation: A Phase 2 Program to Evaluate Emraclidine, a Selective M4 Positive Allosteric Modulator (PAM), for the Treatment of Schizophrenia

A Comparative Study on the Lysosomal Cation Channel TMEM175 Using Automated Whole-Cell Patch-Clamp, Lysosomal Patch-Clamp, and Solid Supported Membrane-Based Electrophysiology: Functional Characterization and High-Throughput Screening Assay Development

Clinical Parkinsonism & Related Disorders: Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment

WPC 2023 Poster: Medication Experiences of People with Parkinson’s Disease

ATS 2023: Novel Orally Bioavailable PDE4B Selective Inhibitors to Treat Inflammatory Diseases

SIRS 2023 Poster: Quantifying the tolerability of antipsychotic treatment-related side effects in schizophrenia: a survey study of patients and caregiver proxies

AAN 2023 Poster: Perspectives on Parkinson's Disease Medications: A Qualitative Study of People with Parkinson's Disease

AAN 2023 Poster: Darigabat Reduces Acute Panic and Fear Symptoms Induced by CO2 Inhalation in Healthy Participants

ADPD 2023 Poster: Impact of the Highly Selective D1-Like Partial Dopamine Agonist Tavapadon on Daytime Sleepiness: Evidence From a Phase 2 Clinical Trial

Efficacy of Subtype-Selective, Full vs Partial M4 Muscarinic Receptor Agonists in Modulating Amphetamine-Induced Brain Activity Assessed by Functional MRI (fMRI) in Rats